Latest Market News

The Takeovers Panel has received a contentious application challenging Keybridge Capital’s role in the Yowie takeover bid, spotlighting conflicts of interest tied to WAM Active’s influence. Interim orders were declined, leaving the dispute unresolved as a critical shareholder meeting unfolds.

Capricorn Metals has fully repaid its remaining $50 million corporate debt ahead of schedule, positioning itself as debt and gold hedging free with strong cash reserves to back growth projects.

GTN Limited is set to seek shareholder approval for a substantial $44 million capital return, aiming to reward investors without compromising its dividend policy.

Global X Management (AUS) Limited has updated the estimated distribution for its Ultra Long Nasdaq 100 Complex ETF, setting it at just over 54 cents per unit for the June 2025 period. Key dates for distribution and dividend reinvestment plan participation are now confirmed.

Aerometrex has renewed and extended its multi-million dollar agreement with Landchecker, significantly increasing its annual recurring revenue through the MetroMap platform.

GBM Resources has completed the first tranche of its capital raising, issuing nearly 245 million shares at $0.006 each, while the second tranche and additional securities await shareholder approval.

Silk Logistics Holdings and DP World Australia have agreed to push back the deadline for their acquisition deal, awaiting a key regulatory decision from the ACCC.

Andromeda Metals has launched a $5 million capital raising via a Placement, accompanied by Placement and Broker Options, to advance its flagship Great White Project and High Purity Alumina development.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.

Epsilon Healthcare and its subsidiaries have officially exited voluntary administration and Deeds of Company Arrangement, marking a pivotal recovery milestone supported by significant personal commitments from the new board. The company now shifts focus to strategic growth and rebuilding trust.